{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:51:30Z","timestamp":1787068290677,"version":"build-2736575974"},"reference-count":151,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Lipid Research"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.plipres.2018.08.001","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T13:18:22Z","timestamp":1533820702000},"page":"1-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Lipid storage myopathies: Current treatments and future directions"],"prefix":"10.1016","volume":"72","author":[{"given":"Emily R.","family":"Vasiljevski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Schindeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plipres.2018.08.001_bb0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11910-010-0154-y","article-title":"Lipid storage myopathy","volume":"11","author":"Liang","year":"2011","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.plipres.2018.08.001_bb0010","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mus.21167","article-title":"Clinical and genetic analysis of lipid storage myopathies","volume":"39","author":"Ohkuma","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.plipres.2018.08.001_bb0015","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.tem.2008.08.003","article-title":"Reassessing triglyceride synthesis in adipose tissue","volume":"19","author":"Nye","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.plipres.2018.08.001_bb0020","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.biocel.2009.12.009","article-title":"Lipolysis in adipocytes","volume":"42","author":"Ahmadian","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1042\/bse0420089","article-title":"Fatty acid metabolism in adipose tissue, muscle and liver in health and disease","volume":"42","author":"Frayn","year":"2006","journal-title":"Essays Biochem"},{"key":"10.1016\/j.plipres.2018.08.001_bb0030","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1210\/jc.2002-021464","article-title":"The increase in intramyocellular lipid content is a very early response to training","volume":"88","author":"Schrauwen-Hinderling","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.plipres.2018.08.001_bb0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cmet.2011.12.018","article-title":"Fat signals - lipases and lipolysis in lipid metabolism and signaling","volume":"15","author":"Zechner","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.plipres.2018.08.001_bb0040","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.bbamcr.2016.01.023","article-title":"Carnitine transport and fatty acid oxidation","volume":"1863","author":"Longo","year":"2016","journal-title":"Biochem Biophys Acta"},{"key":"10.1016\/j.plipres.2018.08.001_bb0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev-physiol-021115-105045","article-title":"The biochemistry and physiology of mitochondrial fatty acid \u03b2-oxidation and its genetic disorders","volume":"78","author":"Houten","year":"2016","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0050","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nsmb.3460","article-title":"Clarifying the supercomplex: the higher-order organization of the mitochondrial electron transport chain","volume":"24","author":"Letts","year":"2017","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0055","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1126\/science.1100747","article-title":"Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase","volume":"306","author":"Zimmermann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.plipres.2018.08.001_bb0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.plipres.2010.10.004","article-title":"Lipolysis - a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores","volume":"50","author":"Lass","year":"2011","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.plipres.2018.08.001_bb0065","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1194\/jlr.M019182","article-title":"Regulation of skeletal muscle lipolysis and oxidative metabolism by the co-lipase CGI-58","volume":"53","author":"Badin","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.08.001_bb0070","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1074\/jbc.M110.180711","article-title":"Interactions of perilipin-5 (Plin5) with adipose triglyceride lipase","volume":"286","author":"Granneman","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.08.001_bb0075","doi-asserted-by":"crossref","first-page":"17958","DOI":"10.1073\/pnas.0506440102","article-title":"Locating high-affinity fatty acid-binding sites on albumin by X-ray crystallography and NMR spectroscopy","volume":"102","author":"Simard","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.plipres.2018.08.001_bb0080","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2133\/dmpk.24.300","article-title":"Albumin as fatty acid transporter","volume":"24","author":"van der Vusse","year":"2009","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.plipres.2018.08.001_bb0085","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/PL00000621","article-title":"Cellular uptake of long-chain fatty acids: role of membrane-associated fatty-acid-binding\/transport proteins","volume":"57","author":"Dutta-Roy","year":"2000","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.plipres.2018.08.001_bb0090","doi-asserted-by":"crossref","first-page":"36235","DOI":"10.1074\/jbc.M400566200","article-title":"A novel function for fatty acid translocase (FAT)\/CD36: involvement in long chain fatty acid transfer into the mitochondria","volume":"279","author":"Campbell","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.08.001_bb0095","doi-asserted-by":"crossref","first-page":"29369","DOI":"10.1074\/jbc.M107022200","volume":"277","author":"Weimar","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.08.001_bb0100","doi-asserted-by":"crossref","first-page":"20378","DOI":"10.1074\/jbc.273.32.20378","article-title":"Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2","volume":"272","author":"Tamai","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.08.001_bb0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000443556","article-title":"Fatty acid beta-oxidation disorders: a brief review","volume":"23","author":"Vishwanath","year":"2016","journal-title":"Ann Neurosci"},{"key":"10.1016\/j.plipres.2018.08.001_bb0110","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/mus.24552","article-title":"Fulminant lipid storage myopathy due to multiple acyl-coenzyme a dehydrogenase deficiency","volume":"52","author":"Whitaker","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.plipres.2018.08.001_bb0115","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/35072063","article-title":"The genetics and pathology of oxidative phosphorylation","volume":"2","author":"Smeitink","year":"2001","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.plipres.2018.08.001_bb0120","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.0954-6820.1953.tb07038.x","article-title":"The familial occurrence of fat containing vacuoles in the leukocytes diagnosed in two brothers suffering from dystrophia musculorum progressiva (ERB)","volume":"145","author":"Jordans","year":"1953","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.plipres.2018.08.001_bb0125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ng1951","article-title":"The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy","volume":"39","author":"Fischer","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.plipres.2018.08.001_bb0130","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.nmd.2013.08.008","article-title":"PNPLA2 mutation: a paediatric case with early onset but indolent course","volume":"23","author":"Perrin","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.plipres.2018.08.001_bb0135","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00415-011-6055-4","article-title":"The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene","volume":"258","author":"Reilich","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0140","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bbrc.2012.10.127","article-title":"Subclinical myopathy in a child with neutral lipid storage disease and mutations in the PNPLA2 gene","volume":"430","author":"Fiorillo","year":"2013","journal-title":"Biochem Biophys Res Comm"},{"key":"10.1016\/j.plipres.2018.08.001_bb0145","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archneurol.2011.631","article-title":"Blocked muscle fat oxidation during exercise in neutral lipid storage disease","volume":"69","author":"Lafor\u00eat","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0150","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1074\/jbc.M110355200","article-title":"Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis","volume":"277","author":"Haemmerle","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.08.001_bb0155","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.1123965","article-title":"Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase","volume":"312","author":"Haemmerle","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.plipres.2018.08.001_bb0160","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/en.2010-0661","article-title":"Adipose triglyceride lipase-null mice are resistant to high-fat diet-induced insulin resistance despite reduced energy expenditure and ectopic lipid accumulation","volume":"152","author":"Hoy","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.plipres.2018.08.001_bb0165","doi-asserted-by":"crossref","first-page":"13850","DOI":"10.1073\/pnas.1516004112","article-title":"Hypophagia and metabolic adaptations in mice with defective ATGL-mediated lipolysis cause resistance to HFD-induced obesity","volume":"112","author":"Schreiber","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.plipres.2018.08.001_bb0170","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/nm.2439","article-title":"ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-alpha and PGC-1","volume":"17","author":"Haemmerle","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.plipres.2018.08.001_bb0175","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.nmd.2014.04.001","article-title":"A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review","volume":"24","author":"Kaneko","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.plipres.2018.08.001_bb0180","doi-asserted-by":"crossref","first-page":"28210","DOI":"10.1074\/jbc.272.45.28210","article-title":"Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators","volume":"272","author":"Martin","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.08.001_bb0185","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijcard.2016.02.082","article-title":"Whole exome sequence analysis reveals a homozygous mutation in PNPLA2 as the cause of severe dilated cardiomyopathy secondary to neutral lipid storage disease","volume":"210","author":"Muggenthaler","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0190","first-page":"51","article-title":"Effects of bezafibrate treatment in a patient and a carrier with mutations in the pnpla2 gene, causing neutral lipid storage disease with myopathy","volume":"112","author":"Weijer","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.plipres.2018.08.001_bb0195","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.1093\/hmg\/dds388","article-title":"Contribution of novel ATGL missense mutations to the clinical phenotype of NLSD-M: a strikingly low amount of lipase activity may preserve cardiac function","volume":"21","author":"Tavian","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.plipres.2018.08.001_bb0200","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cmet.2006.03.005","article-title":"Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome","volume":"3","author":"Lass","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.plipres.2018.08.001_bb0205","doi-asserted-by":"crossref","first-page":"30490","DOI":"10.1074\/jbc.M403920200","article-title":"CGI-58 interacts with perilipin and is localized to lipid droplets. Possible involvement of CGI-58 mislocalization in Chanarin-Dorfman syndrome","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.08.001_bb0210","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00005176-199711000-00011","article-title":"Neutral lipid storage disease with fatty liver and cholestasis","volume":"25","author":"Igal","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.plipres.2018.08.001_bb0215","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4161\/derm.3.2.15472","article-title":"Fat in the skin: triacylglycerol metabolism in keratinocytes and its role in the development of neutral lipid storage disease","volume":"3","author":"Radner","year":"2011","journal-title":"Dermatol Endocrinol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0220","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2133.2005.06828.x","article-title":"Erythrokeratoderma variabilis-like ichthyosis in Chanarin-Dorfman syndrome","volume":"153","author":"Pujol","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0225","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jdermsci.2009.10.016","article-title":"Epidermal triglyceride levels are correlated with severity of ichthyosis in Dorfman\u2013Chanarin syndrome","volume":"57","author":"Ujihara","year":"2010","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.plipres.2018.08.001_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mus.880020102","article-title":"Lipid storage myopathy, ichthyosis, and steatorrhea","volume":"2","author":"Miranda","year":"1979","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.plipres.2018.08.001_bb0235","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12664-012-0212-2","article-title":"Dorfman-Chanarin syndrome","volume":"31","author":"Chilkar","year":"2012","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0240","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/jdv.12651","article-title":"Chanarin\u2013Dorfman syndrome in three siblings in a non-consanguineous family","volume":"30","author":"Gomez-Moyano","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0245","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejmg.2015.01.011","article-title":"Chanarin-Dorfman syndrome: genotype-phenotype correlation","volume":"58","author":"Nur","year":"2015","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.plipres.2018.08.001_bb0250","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4103\/0022-3859.138826","article-title":"Chanarin-Dorfman syndrome: clinical report and novel mutation in ABHD5 gene","volume":"60","author":"Tamhankar","year":"2014","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.plipres.2018.08.001_bb0255","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/pde.12170","article-title":"Acitretin responsive ichthyosis in chanarin\u2013dorfman syndrome with a novel mutation in the ABHD5\/CGI58 gene","volume":"31","author":"Srinivasaraghavan","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0260","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2230.2011.04164.x","article-title":"Beneficial effect of acitretin in Chanarin-Dorfman syndrome: beneficial effect of acitretin in CDS","volume":"37","author":"Israeli","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0265","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4103\/ijd.IJD_613_16","article-title":"Chanarin-Dorfman syndrome with absent Jordan's anomaly","volume":"62","author":"Arora","year":"2017","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0270","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ymgme.2014.10.016","article-title":"Cerebral lipid accumulation in Chanarin-Dorfman syndrome","volume":"114","author":"Huigen","year":"2015","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.plipres.2018.08.001_bb0275","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s004310100838","article-title":"Clinical and biochemical effects of zileuton in patients with the Sjogren-Larsson syndrome","volume":"160","author":"Willemsen","year":"2001","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.plipres.2018.08.001_bb0280","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1074\/jbc.M109.081877","article-title":"Growth retardation, impaired triacylglycerol catabolism, hepatic steatosis, and lethal skin barrier defect in mice lacking comparative gene identification-58 (CGI-58)","volume":"285","author":"Franz","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.08.001_bb0285","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jid.2016.09.025","article-title":"Skin barrier development depends on CGI-58 protein expression during late-stage keratinocyte differentiation","volume":"137","author":"Grond","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0290","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ymgmr.2014.04.008","article-title":"Residual OCTN2 transporter activity, carnitine levels and symptoms correlate in patients with primary carnitine deficiency","volume":"1","author":"Rasmussen","year":"2014","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.plipres.2018.08.001_bb0295","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/humu.21607","article-title":"Genotype-phenotype correlation in primary carnitine deficiency","volume":"33","author":"Rose","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.plipres.2018.08.001_bb0300","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1196\/annals.1320.004","article-title":"Carnitine deficiency disorders in children","volume":"1033","author":"Stanley","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.plipres.2018.08.001_bb0305","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2165\/00003088-200342110-00002","article-title":"Pharmacokinetics of L-carnitine","volume":"42","author":"Evans","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.plipres.2018.08.001_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/646171","article-title":"Potential therapeutic role of l-carnitine in skeletal muscle oxidative stress and atrophy conditions","volume":"2015","author":"Montesano","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.plipres.2018.08.001_bb0315","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.lfs.2005.05.103","article-title":"Antioxidant and antiradical activities of l-carnitine","volume":"78","author":"G\u00fcl\u00e7in","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.plipres.2018.08.001_bb0320","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijcard.2011.11.010","article-title":"Thirty-year follow-up of carnitine supplementation in two siblings with hypertrophic cardiomyopathy caused by primary systemic carnitine deficiency","volume":"159","author":"Kishimoto","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0325","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijcard.2012.05.038","article-title":"Primary carnitine deficiency dilated cardiomyopathy: 28 years follow-up","volume":"162","author":"Agnetti","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0330","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ejhg.2017.22","article-title":"Exome sequencing identifies primary carnitine deficiency in a family with cardiomyopathy and sudden death","volume":"25","author":"Lahrouchi","year":"2017","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.plipres.2018.08.001_bb0335","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000448321","article-title":"Primary carnitine deficiency and newborn screening for disorders of the carnitine cycle","volume":"68","author":"Longo","year":"2016","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.plipres.2018.08.001_bb0340","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1093\/hmg\/8.12.2247","article-title":"Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency","volume":"8","author":"Koizumi","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.plipres.2018.08.001_bb0345","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00125817-199811000-00008","article-title":"Defective urinary carnitine transport in heterozygotes for primary carnitine deficiency","volume":"1","author":"Scaglia","year":"1998","journal-title":"Genet Med"},{"key":"10.1016\/j.plipres.2018.08.001_bb0350","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/GIM.0b013e3181c5e6f7","article-title":"Maternal systemic primary carnitine deficiency uncovered by newborn screening: clinical, biochemical, and molecular aspects","volume":"12","author":"El-Hattab","year":"2010","journal-title":"Genet Med"},{"key":"10.1016\/j.plipres.2018.08.001_bb0355","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10545-006-0376-y","article-title":"Carnitine transporter defect: diagnosis in asymptomatic adult women following analysis of acylcarnitines in their newborn infants","volume":"29","author":"Vijay","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.plipres.2018.08.001_bb0360","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0024-3205(01)01254-1","article-title":"The effect of pivalate treatment of pregnant rats on body mass and insulin levels in the adult offspring","volume":"69","author":"Ricciolini","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.plipres.2018.08.001_bb0365","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10557-016-6647-4","article-title":"A moderate carnitine deficiency exacerbates isoproterenol-induced myocardial injury in rats","volume":"30","author":"Giudice","year":"2016","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.plipres.2018.08.001_bb0370","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/0006-291X(91)91532-H","article-title":"Animal model of systemic carnitine deficiency: analysis in C3H-H-2 degrees strain of mouse associated with juvenile visceral steatosis","volume":"174","author":"Kuwajima","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.plipres.2018.08.001_bb0375","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/HYPERTENSIONAHA.107.088609","article-title":"Pressure overload-induced cardiomyopathy in heterozygous carrier mice of carnitine transporter gene mutation","volume":"50","author":"Takahashi","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.plipres.2018.08.001_bb0380","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10545-012-9488-8","article-title":"Primary carnitine deficiency and pivalic acid exposure causing encephalopathy and fatal cardiac events","volume":"36","author":"Rasmussen","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.plipres.2018.08.001_bb0385","doi-asserted-by":"crossref","first-page":"226","DOI":"10.6065\/apem.2016.21.4.226","article-title":"Systemic primary carnitine deficiency with hypoglycemic encephalopathy","volume":"21","author":"Jun","year":"2016","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"10.1016\/j.plipres.2018.08.001_bb0390","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/mus.24552","article-title":"Fulminant lipid storage myopathy due to multiple acyl-coenzyme a dehydrogenase deficiency: lipid storage myopathy","volume":"52","author":"Whitaker","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.plipres.2018.08.001_bb0395","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/humu.10226","article-title":"Clear relationship between ETF\/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation deficiency","volume":"22","author":"Olsen","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.plipres.2018.08.001_bb0400","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1038\/hgv.2015.16","article-title":"A novel ETFB mutation in a patient with glutaric aciduria type II","volume":"1","author":"Sudo","year":"2015","journal-title":"Hum Genome Var"},{"key":"10.1016\/j.plipres.2018.08.001_bb0405","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jns.2017.11.012","article-title":"A novel mutation in ETFDH manifesting as severe neonatal-onset multiple acyl-CoA dehydrogenase deficiency","volume":"384","author":"van der Westhuizen","year":"2018","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.plipres.2018.08.001_bb0410","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neurol.2015.11.008","article-title":"Multiple acyl-CoA dehydrogenase deficiency (MADD) as a cause of late-onset treatable metabolic disease","volume":"172","author":"B\u00e9hin","year":"2016","journal-title":"Rev Neurol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0415","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.ajhg.2016.04.006","article-title":"Riboflavin-responsive and -non-responsive mutations in fad synthase cause multiple acyl-coa dehydrogenase and combined respiratory-chain deficiency","volume":"98","author":"Olsen","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.plipres.2018.08.001_bb0420","unstructured":"van Rijt, W.J., et al., Favorable outcome after physiologic dose of sodium-D,L-3-hydroxybutyrate in severe MADD. Pediatrics 134 (2014) 1224\u20131228."},{"key":"10.1016\/j.plipres.2018.08.001_bb0425","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1399-0004.2010.01421.x","article-title":"High frequency of ETFDH c.250G>A mutation in Taiwanese patients with late-onset lipid storage myopathy","volume":"78","author":"Lan","year":"2010","journal-title":"Clin Genet"},{"key":"10.1016\/j.plipres.2018.08.001_bb0430","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.braindev.2016.08.004","article-title":"Efficacy of bezafibrate on fibroblasts of glutaric acidemia type II patients evaluated using an in vitro probe acylcarnitine assay","volume":"39","author":"Yamada","year":"2017","journal-title":"Brain Dev"},{"key":"10.1016\/j.plipres.2018.08.001_bb0435","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10545-006-0266-3","article-title":"Potential of fibrates in the treatment of fatty acid oxidation disorders: revival of classical drugs?","volume":"29","author":"Djouadi","year":"2006","journal-title":"J Inherit Metabol Dis"},{"key":"10.1016\/j.plipres.2018.08.001_bb0440","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.braindev.2009.06.001","article-title":"Effect of heat stress and bezafibrate on mitochondrial \u03b2-oxidation: comparison between cultured cells from normal and mitochondrial fatty acid oxidation disorder children using in vitro probe acylcarnitine profiling assay","volume":"32","author":"Li","year":"2010","journal-title":"Brain Dev"},{"key":"10.1016\/j.plipres.2018.08.001_bb0445","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ymgme.2012.07.004","article-title":"Bezafibrate can be a new treatment option for mitochondrial fatty acid oxidation disorders: evaluation by in vitro probe acylcarnitine assay","volume":"107","author":"Yamaguchi","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.plipres.2018.08.001_bb0450","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jns.2014.08.040","article-title":"Amelioration of acylcarnitine profile using bezafibrate and riboflavin in a case of adult-onset glutaric acidemia type 2 with novel mutations of the electron transfer flavoprotein dehydrogenase (ETFDH) gene","volume":"346","author":"Shioya","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.plipres.2018.08.001_bb0455","doi-asserted-by":"crossref","first-page":"8329","DOI":"10.1371\/journal.pone.0008329","article-title":"Mechanisms underlying metabolic and neural defects in zebrafish and human multiple acyl-CoA dehydrogenase deficiency (MADD)","volume":"4","author":"Song","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.plipres.2018.08.001_bb0460","doi-asserted-by":"crossref","first-page":"1003563","DOI":"10.1371\/journal.pgen.1003563","article-title":"Multi-organ abnormalities and mTORC1 activation in zebrafish model of multiple acyl-CoA dehydrogenase deficiency","volume":"9","author":"Kim","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.plipres.2018.08.001_bb0465","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4103\/0366-6999.173438","article-title":"A historical cohort study on the efficacy of glucocorticoids and riboflavin among patients with late-onset multiple acyl-coa dehydrogenase deficiency","volume":"129","author":"Liu","year":"2016","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.plipres.2018.08.001_bb0470","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.metabol.2011.06.012","article-title":"The effects of glucocorticoids on adipose tissue lipid metabolism","volume":"60","author":"Peckett","year":"2011","journal-title":"Metabol Clin Exp"},{"key":"10.1016\/j.plipres.2018.08.001_bb0475","first-page":"161","article-title":"Skeletal muscle and motor deficits in neurofibromatosis type 1","volume":"15","author":"Summers","year":"2015","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.plipres.2018.08.001_bb0480","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/dmcn.12777","article-title":"Muscle weakness in children with neurofibromatosis type 1","volume":"57","author":"Cornett","year":"2015","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0485","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/hmg\/ddt515","article-title":"NF1 is a critical regulator of muscle development and metabolism","volume":"23","author":"Sullivan","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.plipres.2018.08.001_bb0490","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/hmg\/ddm032","article-title":"Multiple roles for neurofibromin in skeletal development and growth","volume":"16","author":"Kolanczyk","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.plipres.2018.08.001_bb0495","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/hmg\/ddx423","article-title":"Dietary intervention rescues myopathy associated with neurofibromatosis type 1","volume":"27","author":"Summers","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.plipres.2018.08.001_bb0500","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2474-13-103","article-title":"Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis","volume":"13","author":"Smoyer-Tomic","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.plipres.2018.08.001_bb0505","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1212\/WNL.58.3.438","article-title":"Three lipoprotein receptors and cholesterol in inclusion-body myositis muscle","volume":"58","author":"Jaworska-Wilczynska","year":"2002","journal-title":"Neurologia"},{"key":"10.1016\/j.plipres.2018.08.001_bb0510","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1468-3083.2011.04437.x","article-title":"Lipid profiles in untreated patients with dermatomyositis","volume":"27","author":"Wang","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0515","doi-asserted-by":"crossref","first-page":"89827","DOI":"10.1371\/journal.pone.0089827","article-title":"Altered lipid levels in untreated patients with early polymyositis","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.plipres.2018.08.001_bb0520","first-page":"609","article-title":"Muscle lipids is polymyositis","volume":"37","author":"Dudley","year":"1978","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0525","article-title":"Treatment for inclusion body myositis","volume":"6","author":"Rose","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.plipres.2018.08.001_bb0530","unstructured":"Amato, A.A., et al. A Randomized, Double-blind, Placebo-controlled Study of Bimagrumab in Patients With Sporadic Inclusion Body Myositis. Hoboken: Wiley"},{"key":"10.1016\/j.plipres.2018.08.001_bb0535","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10072-011-0657-6","article-title":"Pilot trial of simvastatin in the treatment of sporadic inclusion-body myositis","volume":"32","author":"Sancricca","year":"2011","journal-title":"Neurol Sci"},{"key":"10.1016\/j.plipres.2018.08.001_bb0540","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1592\/phco.30.6.541","article-title":"Statin associated muscle related adverse effects: a case series of 354 patients","volume":"30","author":"Cham","year":"2010","journal-title":"J Hum Pharmacol Drug Therapy"},{"key":"10.1016\/j.plipres.2018.08.001_bb0545","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00296-017-3821-3","article-title":"Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review","volume":"38","author":"Borges","year":"2018","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.plipres.2018.08.001_bb0550","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijcard.2016.01.137","article-title":"Severe cardiomyopathy in a young patient with complete deficiency of adipose triglyceride lipase due to a novel mutation in PNPLA2 gene","volume":"207","author":"Pasanisi","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0555","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/mus.24477","article-title":"A myopathy with unusual features caused by PNPLA2 gene mutations","volume":"51","author":"Pennisi","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.plipres.2018.08.001_bb0560","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.nmd.2014.04.001","article-title":"A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review","volume":"24","author":"Kaneko","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.plipres.2018.08.001_bb0565","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/bjd.15156","article-title":"Chanarin\u2013Dorfman syndrome with rare renal involvement","volume":"176","author":"Verma","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0570","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.gene.2015.09.004","article-title":"Chanarin Dorfman syndrome: a case report with novel nonsense mutation","volume":"575","author":"Gupta","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.plipres.2018.08.001_bb0575","first-page":"787","article-title":"Chanarin-Dorfman syndrome","volume":"26","author":"Waheed","year":"2016","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/j.plipres.2018.08.001_bb0580","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/jgh.12852","article-title":"Education and imaging. Hepatology: Chanarin-Dorfman syndrome, a rare cause of fatty liver and steatohepatitis","volume":"30","author":"Kazemi","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0585","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2350-15-32","article-title":"Early onset of Chanarin-Dorfman syndrome with severe liver involvement in a patient with a complex rearrangement of ABHD5 promoter","volume":"15","author":"Missaglia","year":"2014","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.plipres.2018.08.001_bb0590","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s12664-017-0790-0","article-title":"Infant with hepatomegaly and hypoglycemia: a setting for fatty acid oxidation defects","volume":"36","author":"Ravindranath","year":"2017","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0595","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.tacc.2017.01.061","article-title":"A combination of dexmedetomidine and ketamine for a child with primary carnitine deficiency posted for cataract extraction","volume":"13","author":"Ganigara","year":"2017","journal-title":"Trends Anaesth. Critic. Care"},{"key":"10.1016\/j.plipres.2018.08.001_bb0600","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12098-016-2227-7","article-title":"Primary carnitine deficiency \u2013 a rare treatable cause of cardiomyopathy and massive hepatomegaly","volume":"84","author":"Deswal","year":"2017","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.plipres.2018.08.001_bb0605","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4103\/0028-3886.173650","article-title":"Primary carnitine deficiency as a cause of metabolic leukoencephalopathy: report of one case","volume":"64","author":"Mahale","year":"2016","journal-title":"Neurol India"},{"key":"10.1016\/j.plipres.2018.08.001_bb0610","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-210727","article-title":"Reversible weakness and encephalopathy while on long-term valproate treatment due to carnitine deficiency","volume":"2015","author":"Al-Sharefi","year":"2015","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.plipres.2018.08.001_bb0615","first-page":"259627","article-title":"Identification of SLC22A5 gene mutation in a family with carnitine uptake defect","volume":"2015","author":"Mutlu-Albayrak","year":"2015","journal-title":"Case Rep Genet"},{"key":"10.1016\/j.plipres.2018.08.001_bb0620","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/jon.12102","article-title":"MRI findings in encephalopathy with primary carnitine deficiency: a case report","volume":"25","author":"Yilmaz","year":"2015","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.plipres.2018.08.001_bb0625","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4103\/0028-3886.156308","article-title":"Primary carnitine deficiency presenting as intractable seizures","volume":"63","author":"Kumar","year":"2015","journal-title":"Neurol India"},{"key":"10.1016\/j.plipres.2018.08.001_bb0630","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1515\/jpem-2014-0528","article-title":"Primary systemic carnitine deficiency: a Turkish case with a novel homozygous SLC22A5 mutation and 14 years follow-up","volume":"28","author":"Yilmaz","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.plipres.2018.08.001_bb0635","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijcard.2014.03.190","article-title":"Primary carnitine deficiency cardiomyopathy","volume":"174","author":"Wang","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0640","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/8904_2011_36","article-title":"Identification of mutations and evaluation of cardiomyopathy in Turkish patients with primary carnitine deficiency","volume":"3","author":"Kilic","year":"2012","journal-title":"JIMD Rep"},{"key":"10.1016\/j.plipres.2018.08.001_bb0645","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/8904_2011_52","article-title":"Primary carnitine deficiency presents atypically with long QT syndrome: a case report","volume":"2","author":"De Biase","year":"2012","journal-title":"JIMD Rep"},{"key":"10.1016\/j.plipres.2018.08.001_bb0650","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000333127","article-title":"Primary carnitine deficiency and sudden death: in vivo evidence of myocardial lipid peroxidation and sulfonylation of sarcoendoplasmic reticulum calcium ATPase 2","volume":"120","author":"Mazzini","year":"2011","journal-title":"Cardiology"},{"key":"10.1016\/j.plipres.2018.08.001_bb0655","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ymgme.2017.10.014","article-title":"An intronic variation in SLC52A1 causes exon skipping and transient riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency","volume":"122","author":"Mosegaard","year":"2017","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.plipres.2018.08.001_bb0660","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/ene.13319","article-title":"Riboflavin responsive multiple acyl-CoA dehydrogenase deficiency: delayed hypersensitivity reaction and efficacy of low dose intermittent supplementation","volume":"24","author":"Vattemi","year":"2017","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/8904_2017_38","article-title":"Successful pregnancy in a young woman with multiple acyl-coa dehydrogenase deficiency","volume":"39","author":"Creanza","year":"2017","journal-title":"JIMD Rep"},{"key":"10.1016\/j.plipres.2018.08.001_bb0670","first-page":"177","article-title":"Multiple acyl CoA dehydrogenase deficiency: uncommon yet treatable disorder","volume":"65","author":"Pooja","year":"2018","journal-title":"Neurol India"},{"key":"10.1016\/j.plipres.2018.08.001_bb0675","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.nmd.2017.08.004","article-title":"Fatty acid oxidation defects presenting as primary myopathy and prominent dropped head syndrome","volume":"27","author":"Vengalil","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.plipres.2018.08.001_bb0680","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s10072-016-2549-2","article-title":"Significant clinical heterogeneity with similar ETFDH genotype in three Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency","volume":"37","author":"Fu","year":"2016","journal-title":"Neurol Sci"},{"key":"10.1016\/j.plipres.2018.08.001_bb0685","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.nmd.2015.12.002","article-title":"Severe sensory neuropathy in patients with adult-onset multiple acyl-CoA dehydrogenase deficiency","volume":"26","author":"Wang","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.plipres.2018.08.001_bb0690","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12883-015-0380-7","article-title":"Bent spine syndrome as an initial manifestation of late-onset multiple acyl-CoA dehydrogenase deficiency: a case report and literature review","volume":"15","author":"Peng","year":"2015","journal-title":"BMC Neurol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0695","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jns.2015.04.011","article-title":"A case of late-onset riboflavin responsive multiple acyl-CoA dehydrogenase deficiency (MADD) with a novel mutation in ETFDH gene","volume":"353","author":"Zhuo","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.plipres.2018.08.001_bb0700","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10072-015-2197-y","article-title":"Multiple acyl-CoA dehydrogenation deficiency as decreased acyl-carnitine profile in serum","volume":"36","author":"Wen","year":"2015","journal-title":"Neurol Sci"},{"key":"10.1016\/j.plipres.2018.08.001_bb0705","first-page":"92","article-title":"Glutaric aciduria type 2 presenting with acute respiratory failure in an adult","volume":"15","author":"Ersoy","year":"2015","journal-title":"Respir Med Case Rep"},{"issue":"1\u20131","key":"10.1016\/j.plipres.2018.08.001_bb0710","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/pr.2014.154","article-title":"Highly efficient ketone body treatment in multiple acyl-CoA dehydrogenase deficiency-related leukodystrophy","volume":"77","author":"Gautschi","year":"2015","journal-title":"Pediatr Res"},{"key":"10.1016\/j.plipres.2018.08.001_bb0715","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/mus.23979","article-title":"Novel ETFDH mutation and imaging findings in an adult with glutaric aciduria type II","volume":"49","author":"Rosenbohm","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.plipres.2018.08.001_bb0720","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/jhg.2014.10","article-title":"Riboflavin-responsive multiple Acyl-CoA dehydrogenation deficiency in 13 cases, and a literature review in mainland Chinese patients","volume":"59","author":"Zhu","year":"2014","journal-title":"J Hum Genet"},{"key":"10.1016\/j.plipres.2018.08.001_bb0725","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ymgme.2013.04.007","article-title":"Increased muscle coenzyme Q10 in riboflavin responsive MADD with ETFDH gene mutations due to secondary mitochondrial proliferation","volume":"109","author":"Wen","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.plipres.2018.08.001_bb0730","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/cns.12007","article-title":"A case of late onset riboflavin responsive multiple acyl-coa dehydrogenase deficiency with novel mutations in ETFDH gene","volume":"18","author":"Zhao","year":"2012","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.plipres.2018.08.001_bb0735","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ymgme.2012.05.001","article-title":"Pregnancy of a patient with multiple Acyl-CoA dehydrogenation deficiency (MADD)","volume":"106","author":"Trakadis","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.plipres.2018.08.001_bb0740","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s10072-011-0900-1","article-title":"Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency with unknown genetic defect","volume":"33","author":"Cotelli","year":"2012","journal-title":"Neurol Sci"},{"key":"10.1016\/j.plipres.2018.08.001_bb0745","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejpn.2011.07.003","article-title":"Developmental evolution in a patient with multiple acyl-coenzymeA dehydrogenase deficiency under pharmacological treatment","volume":"16","author":"Rosa","year":"2011","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.plipres.2018.08.001_bb0750","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.2169\/internalmedicine.50.5172","article-title":"A case of late onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency manifesting as recurrent rhabdomyolysis and acute renal failure","volume":"50","author":"Izumi","year":"2011","journal-title":"Int. Med. (Tokyo, Japan)"},{"key":"10.1016\/j.plipres.2018.08.001_bb0755","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/mus.21881","article-title":"Subacute myopathy in a mature patient due to multiple acyl coenzyme a dehydrogenase deficiency","volume":"43","author":"Kaminsky","year":"2011","journal-title":"Muscle Nerve"}],"container-title":["Progress in Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163782718300171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163782718300171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T04:20:04Z","timestamp":1751775604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163782718300171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":151,"alternative-id":["S0163782718300171"],"URL":"https:\/\/doi.org\/10.1016\/j.plipres.2018.08.001","relation":{},"ISSN":["0163-7827"],"issn-type":[{"value":"0163-7827","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid storage myopathies: Current treatments and future directions","name":"articletitle","label":"Article Title"},{"value":"Progress in Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plipres.2018.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2018 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}